Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1 Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland OH, USA, 2 National Institute on Drug Abuse, National Institutes of Health, Bethesda MD, USA
Список исп. литературыСкрыть список 1. World Health Organization . WHO coronavirus disease (COVID-19) dashboard. https://covid19.who.int. 2. Centers for Disease Control and Prevention . Groups at higher risk for COVID-19 severe illness. https://www.cdc.gov/coronavirus. 3. Richardson S, Hirsch JS, Narasimhan M et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020;323:2052-9. 4. Myers LC, Parodi SM, Escobar GJ et al. Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California. JAMA 2020;323:2195-8. 5. Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62. 6. World Health Organization . Mental disorders. https://www.who.int. 7. Adhanom Ghebreyesus T. Addressing mental health needs: an integral part of COVID-19 response. World Psychiatry 2020;19:129-30. 8. Li J, Yang Z, Qiu H et al. Anxiety and depression among general population in China at the peak of the COVID-19 pandemic. World Psychiatry 2020;19:249-50. 9. Yao H, Chen JH, Xu YF. Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry 2020;7:e21. 10. Shinn AK, Viron M. Perspectives on the COVID-19 pandemic and individuals with serious mental illness. J Clin Psychiatry 2020;81:20com13412. 11. McGuire TG, Miranda J. New evidence regarding racial and ethnic disparities in mental health: policy implications. Health Aff 2008;27:393-403. 12. Alegría M, Chatterji P, Wells K et al. Disparity in depression treatment among racial and ethnic minority populations in the United States. Psychiatr Serv 2008;59:1264-72. 13. Alegría M, Falgas-Bague I, Fong H. Engagement of ethnic minorities in mental health care. World Psychiatry 2020;19:35-6. 14. World Health Organization . Gender and women’s mental health. Geneva: World Health Organization, 2020. 15. Yancy CW. COVID-19 and African Americans. JAMA 2020;323:1891-2. 16. Burki T. The indirect impact of COVID-19 on women. Lancet Infect Dis 2020;20:904-5. 17. The Lancet. The gendered dimensions of COVID-19. Lancet 2020;395:1168. 18. United Nations. The impact of COVID-19 on women. https://www.unwomen.org. 19. International Business Machines (IBM). Explorys EHR solutions. https://www.ibm.com. 20. Bodenreider O. The unified medical language system (UMLS): integrating biomedical terminology. Nucleic Acids Res 2004;32:D267-70. 21. SNOMED International . The systematized nomenclature of medicine – clinical terms (SNOMED CT). http://www.snomed.org. 22. Kaelber DC, Foster W, Gilder J et al. Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data. J Am Med Inform Assoc 2012;19:965-72. 23. International Business Machines (IBM). IBM Explorys EHR database bibliography categorized by therapeutic area. https://www.ibm.com. 24. Zhou M, Xu R, Kaelber DC et al. Tumor necrosis factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis. PLoS One 2020;15:e0229819. 25. Zhou M, Zheng CL, Xu R. Combining phenome-driven drug target prediction with patients? Electronic health records-based clinical corroboration towards drug discovery. Bioinformatics 2020;36(Suppl. 1):i436-44. 26. Wang Q, Kaelber D, Xu R et al. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry (in press). 27. Kuritz SJ, Landis JR, Koch GG. A general overview of Mantel-Haenszel methods: applications and recent developments. Annu Rev Public Health 1988;9:123-60. 28. Wasserman D, Iouse M, Wuestefeld A et al. Adaptation of evidence-based suicide prevention strategies during and after the COVID-19 pandemic. World Psychiatry 2020;19:294-306. 29. Dickerson F, Schroeder J, Katsafanas E et al. Cigarette smoking by patients with serious mental illness, 1999-2016: an increasing disparity. Psychiatr Serv 2018;69:147-53. 30. Weinberger AH, Kashan RS, Shpigel DM et al. Depression and cigarette smoking behavior: a critical review of population-based studies. Am J Drug Alcohol Abuse 2017;43:416-31. 31. Prochaska JJ, Das S, Young-Wolff KC. Smoking, mental illness, and public health. Annu Rev Public Health 2017;38:165-85. 32. Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis 2020;18:20. 33. Patanavanich R, Glantz SA. Smoking is associated with COVID-19 progression: a meta-analysis. Nicotine Tob Res 2020;22:1653-6. 34. Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron 2020;107:234-56. 35. Müller N. Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations. Schizophr Bull 2018;44:973-82. 36. Benedetti F, Aggio V, Pratesi ML et al. Neuroinflammation in bipolar depression. Front Psychiatry 2020;11:71. 37. Steardo L Jr, Steardo L, Verkhratsky A. Psychiatric face of COVID-19. Transl Psychiatry 2020;10:261. 38. Centers for Disease Control and Prevention . COVIDView. A weekly surveillance summary of U.S. COVID-19 activity. https://www.cdc.gov. 39. Cowie MR, Blomster JI, Curtis LH et al. Electronic health records to facilitate clinical research. Clin Res Cardiol 2017;106:1-9. 40. Coorevits P, Sundgren M, Klein GO et al. Electronic health records: new opportunities for clinical research. J Intern Med 2013;274:547-60. 41. Ahmad FS, Chan C, Rosenman MB et al. Validity of cardiovascular data from electronic sources: the Multi-Ethnic Study of Atherosclerosis and HealthLNK. Circulation 2017;136:1207-16.